Back
ESC2025 Premium Access

Comparison of phenotype and prognosis of hereditary Val122Ile and wild type transthyretin cardiomyopathy.

Session: Transthyretin cardiac amyloidosis
Topic: Infiltrative Myocardial Disease
Speaker: Professor J. Inamo (Fort de France, MQ)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Professor Jocelyn Inamo

University Hospital of Fort de France, Fort de France (Martinique)
0 follower

5 more presentations in this session

Neurological and cardiological profiling of patients with mutated transthyretin amyloidosis

Speaker: Doctor L. Ordine (Naples, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Overtture study: disease burden at diagnosis in ATTR amyloidosis patients with cardiac impairment in Spain

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Screening for amyloid cardiomyopathy in patients with aortic stenosis

Speaker: Doctor I. Mattig (Berlin, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Characteristics and prognosis of wild-type transthyretin cardiac amyloidosis patients diagnosed before 65 years old

Speaker: Doctor D. Guijarro (Geneva, CH)

Access
Abstract
Slides
Video
Like
Thumbnail

Targeted deployment of AI-ECG for efficient screening of transthyretin amyloid cardiomyopathy using deep learning representations of longitudinal electronic health records

Speaker: Doctor E. Oikonomou (New Haven, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Transthyretin cardiac amyloidosis

Speakers: Professor J. Inamo, Doctor L. Ordine, Doctor P. Garcia-Pavia, Doctor I. Mattig, Doctor D. Guijarro...
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources